Retatrutide, by Soma Pharmaceuticals , represents a exciting development in body regulation. This unique drug combines hormonal receptor activity with GIP pathway engagement, demonstrating substantial potential in trial data for body loss . Experts believe Retatrutide could provide a new solution for people experiencing weight-related issues. Soma